Report cover image

Global Gadolinium-Based Contrast Agents Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20360553

Description

Summary

According to APO Research, the global Gadolinium-Based Contrast Agents market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Gadolinium-Based Contrast Agents market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Gadolinium-Based Contrast Agents market include Agfa, BeiLu Pharma, Bracco Imaging, GE Healthcare, Guerbet Group, Hengrui Medicine, Lantheus, Marotrast and YRPG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gadolinium-Based Contrast Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Gadolinium-Based Contrast Agents, also provides the sales of main regions and countries. Of the upcoming market potential for Gadolinium-Based Contrast Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gadolinium-Based Contrast Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Gadolinium-Based Contrast Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Gadolinium-Based Contrast Agents sales, projected growth trends, production technology, application and end-user industry.

Gadolinium-Based Contrast Agents Segment by Company

Agfa
BeiLu Pharma
Bracco Imaging
GE Healthcare
Guerbet Group
Hengrui Medicine
Lantheus
Marotrast
YRPG
Bayer
Jiangsu Hengrui Medicine
Stary
Gadolinium-Based Contrast Agents Segment by Type

Linear Gadolinium-Based Contrast Agents
Macrocycle Gadolinium-Based Contrast Agents
Gadolinium-Based Contrast Agents Segment by Application

Hospital
Specialist Clinic
Others
Gadolinium-Based Contrast Agents Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Gadolinium-Based Contrast Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Gadolinium-Based Contrast Agents market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gadolinium-Based Contrast Agents significant trends, drivers, influence factors in global and regions.
6. To analyze Gadolinium-Based Contrast Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadolinium-Based Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gadolinium-Based Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadolinium-Based Contrast Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadolinium-Based Contrast Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gadolinium-Based Contrast Agents industry.
Chapter 3: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Gadolinium-Based Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Gadolinium-Based Contrast Agents in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Gadolinium-Based Contrast Agents Sales Value (2020-2031)
1.2.2 Global Gadolinium-Based Contrast Agents Sales Volume (2020-2031)
1.2.3 Global Gadolinium-Based Contrast Agents Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Gadolinium-Based Contrast Agents Market Dynamics
2.1 Gadolinium-Based Contrast Agents Industry Trends
2.2 Gadolinium-Based Contrast Agents Industry Drivers
2.3 Gadolinium-Based Contrast Agents Industry Opportunities and Challenges
2.4 Gadolinium-Based Contrast Agents Industry Restraints
3 Gadolinium-Based Contrast Agents Market by Company
3.1 Global Gadolinium-Based Contrast Agents Company Revenue Ranking in 2024
3.2 Global Gadolinium-Based Contrast Agents Revenue by Company (2020-2025)
3.3 Global Gadolinium-Based Contrast Agents Sales Volume by Company (2020-2025)
3.4 Global Gadolinium-Based Contrast Agents Average Price by Company (2020-2025)
3.5 Global Gadolinium-Based Contrast Agents Company Ranking (2023-2025)
3.6 Global Gadolinium-Based Contrast Agents Company Manufacturing Base and Headquarters
3.7 Global Gadolinium-Based Contrast Agents Company Product Type and Application
3.8 Global Gadolinium-Based Contrast Agents Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Gadolinium-Based Contrast Agents Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Gadolinium-Based Contrast Agents Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Gadolinium-Based Contrast Agents Market by Type
4.1 Gadolinium-Based Contrast Agents Type Introduction
4.1.1 Linear Gadolinium-Based Contrast Agents
4.1.2 Macrocycle Gadolinium-Based Contrast Agents
4.2 Global Gadolinium-Based Contrast Agents Sales Volume by Type
4.2.1 Global Gadolinium-Based Contrast Agents Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Gadolinium-Based Contrast Agents Sales Volume by Type (2020-2031)
4.2.3 Global Gadolinium-Based Contrast Agents Sales Volume Share by Type (2020-2031)
4.3 Global Gadolinium-Based Contrast Agents Sales Value by Type
4.3.1 Global Gadolinium-Based Contrast Agents Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Gadolinium-Based Contrast Agents Sales Value by Type (2020-2031)
4.3.3 Global Gadolinium-Based Contrast Agents Sales Value Share by Type (2020-2031)
5 Gadolinium-Based Contrast Agents Market by Application
5.1 Gadolinium-Based Contrast Agents Application Introduction
5.1.1 Hospital
5.1.2 Specialist Clinic
5.1.3 Others
5.2 Global Gadolinium-Based Contrast Agents Sales Volume by Application
5.2.1 Global Gadolinium-Based Contrast Agents Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Gadolinium-Based Contrast Agents Sales Volume by Application (2020-2031)
5.2.3 Global Gadolinium-Based Contrast Agents Sales Volume Share by Application (2020-2031)
5.3 Global Gadolinium-Based Contrast Agents Sales Value by Application
5.3.1 Global Gadolinium-Based Contrast Agents Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Gadolinium-Based Contrast Agents Sales Value by Application (2020-2031)
5.3.3 Global Gadolinium-Based Contrast Agents Sales Value Share by Application (2020-2031)
6 Gadolinium-Based Contrast Agents Regional Sales and Value Analysis
6.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Gadolinium-Based Contrast Agents Sales by Region (2020-2031)
6.2.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2020-2025
6.2.2 Global Gadolinium-Based Contrast Agents Sales by Region (2026-2031)
6.3 Global Gadolinium-Based Contrast Agents Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Gadolinium-Based Contrast Agents Sales Value by Region (2020-2031)
6.4.1 Global Gadolinium-Based Contrast Agents Sales Value by Region: 2020-2025
6.4.2 Global Gadolinium-Based Contrast Agents Sales Value by Region (2026-2031)
6.5 Global Gadolinium-Based Contrast Agents Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Gadolinium-Based Contrast Agents Sales Value (2020-2031)
6.6.2 North America Gadolinium-Based Contrast Agents Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Gadolinium-Based Contrast Agents Sales Value (2020-2031)
6.7.2 Europe Gadolinium-Based Contrast Agents Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Gadolinium-Based Contrast Agents Sales Value (2020-2031)
6.8.2 Asia-Pacific Gadolinium-Based Contrast Agents Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Gadolinium-Based Contrast Agents Sales Value (2020-2031)
6.9.2 South America Gadolinium-Based Contrast Agents Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Gadolinium-Based Contrast Agents Sales Value (2020-2031)
6.10.2 Middle East & Africa Gadolinium-Based Contrast Agents Sales Value Share by Country, 2024 VS 2031
7 Gadolinium-Based Contrast Agents Country-level Sales and Value Analysis
7.1 Global Gadolinium-Based Contrast Agents Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Gadolinium-Based Contrast Agents Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Gadolinium-Based Contrast Agents Sales by Country (2020-2031)
7.3.1 Global Gadolinium-Based Contrast Agents Sales by Country (2020-2025)
7.3.2 Global Gadolinium-Based Contrast Agents Sales by Country (2026-2031)
7.4 Global Gadolinium-Based Contrast Agents Sales Value by Country (2020-2031)
7.4.1 Global Gadolinium-Based Contrast Agents Sales Value by Country (2020-2025)
7.4.2 Global Gadolinium-Based Contrast Agents Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.5.2 USA Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.6.2 Canada Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.8.2 Germany Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.9.2 France Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.9.3 France Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.11.2 Italy Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.12.2 Spain Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.13.2 Russia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.16.2 China Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.16.3 China Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.17.2 Japan Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.19.2 India Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.19.3 India Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.20.2 Australia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.24.2 Chile Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.26.2 Peru Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.28.2 Israel Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.29.2 UAE Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.31.2 Iran Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Gadolinium-Based Contrast Agents Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Gadolinium-Based Contrast Agents Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Gadolinium-Based Contrast Agents Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Agfa
8.1.1 Agfa Comapny Information
8.1.2 Agfa Business Overview
8.1.3 Agfa Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.1.4 Agfa Gadolinium-Based Contrast Agents Product Portfolio
8.1.5 Agfa Recent Developments
8.2 BeiLu Pharma
8.2.1 BeiLu Pharma Comapny Information
8.2.2 BeiLu Pharma Business Overview
8.2.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.2.4 BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio
8.2.5 BeiLu Pharma Recent Developments
8.3 Bracco Imaging
8.3.1 Bracco Imaging Comapny Information
8.3.2 Bracco Imaging Business Overview
8.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio
8.3.5 Bracco Imaging Recent Developments
8.4 GE Healthcare
8.4.1 GE Healthcare Comapny Information
8.4.2 GE Healthcare Business Overview
8.4.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.4.4 GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio
8.4.5 GE Healthcare Recent Developments
8.5 Guerbet Group
8.5.1 Guerbet Group Comapny Information
8.5.2 Guerbet Group Business Overview
8.5.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.5.4 Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio
8.5.5 Guerbet Group Recent Developments
8.6 Hengrui Medicine
8.6.1 Hengrui Medicine Comapny Information
8.6.2 Hengrui Medicine Business Overview
8.6.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.6.4 Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
8.6.5 Hengrui Medicine Recent Developments
8.7 Lantheus
8.7.1 Lantheus Comapny Information
8.7.2 Lantheus Business Overview
8.7.3 Lantheus Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.7.4 Lantheus Gadolinium-Based Contrast Agents Product Portfolio
8.7.5 Lantheus Recent Developments
8.8 Marotrast
8.8.1 Marotrast Comapny Information
8.8.2 Marotrast Business Overview
8.8.3 Marotrast Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.8.4 Marotrast Gadolinium-Based Contrast Agents Product Portfolio
8.8.5 Marotrast Recent Developments
8.9 YRPG
8.9.1 YRPG Comapny Information
8.9.2 YRPG Business Overview
8.9.3 YRPG Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.9.4 YRPG Gadolinium-Based Contrast Agents Product Portfolio
8.9.5 YRPG Recent Developments
8.10 Bayer
8.10.1 Bayer Comapny Information
8.10.2 Bayer Business Overview
8.10.3 Bayer Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.10.4 Bayer Gadolinium-Based Contrast Agents Product Portfolio
8.10.5 Bayer Recent Developments
8.11 Jiangsu Hengrui Medicine
8.11.1 Jiangsu Hengrui Medicine Comapny Information
8.11.2 Jiangsu Hengrui Medicine Business Overview
8.11.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.11.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
8.11.5 Jiangsu Hengrui Medicine Recent Developments
8.12 Stary
8.12.1 Stary Comapny Information
8.12.2 Stary Business Overview
8.12.3 Stary Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2020-2025)
8.12.4 Stary Gadolinium-Based Contrast Agents Product Portfolio
8.12.5 Stary Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Gadolinium-Based Contrast Agents Value Chain Analysis
9.1.1 Gadolinium-Based Contrast Agents Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Gadolinium-Based Contrast Agents Sales Mode & Process
9.2 Gadolinium-Based Contrast Agents Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Gadolinium-Based Contrast Agents Distributors
9.2.3 Gadolinium-Based Contrast Agents Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.